Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
医学
特应性皮炎
杜皮鲁玛
皮肤病科
作者
Andrew Blauvelt,Henrique D. Teixeira,Eric L. Simpson,Antonio Costanzo,Marjolein de Bruin‐Weller,S. Barbarot,Vimal H. Prajapati,Peter Lio,Xiaofei Hu,Tianshuang Wu,John Liu,Barry Ladizinski,Alvina D. Chu,Kilian Eyerich
出处
期刊:JAMA Dermatology [American Medical Association] 日期:2021-08-04卷期号:157 (9): 1047-1047被引量:343
Atopic dermatitis (AD) is a chronic, recurrent, inflammatory skin disease with an unmet need for treatments that provide rapid and high levels of skin clearance and itch improvement.